Project ASTER: Difference between revisions
→Procedures
No edit summary |
|||
| Line 9: | Line 9: | ||
'''2. Muscular enhancement injections:''' protein complex is injected intramuscularly to increase tissue density and decrease lactase recovery time. Risk: 5 percent of test subjects experience a fatal cardiac volume increase. | '''2. Muscular enhancement injections:''' protein complex is injected intramuscularly to increase tissue density and decrease lactase recovery time. Risk: 5 percent of test subjects experience a fatal cardiac volume increase. | ||
'''3. Catalytic thyroid implant:''' platinum pellet containing human growth hormone catalyst is implanted in the thyroid to boost growth of skeletal and muscle tissues. Risk: rare instances of elephantiasis | '''3. Catalytic thyroid implant:''' platinum pellet containing human growth hormone catalyst is implanted in the thyroid to boost growth of skeletal and muscle tissues, suppressed sexual drive. Risk: rare instances of elephantiasis. | ||
'''4. Occipital capillary reversal:''' submergence and boosted blood vessel flow beneath the rods and cones of subject’s retina. Produces a marked visual perception increase. Risk: retinal rejection and detachment. Permanent blindness. | '''4. Occipital capillary reversal:''' submergence and boosted blood vessel flow beneath the rods and cones of subject’s retina. Produces a marked visual perception increase. Risk: retinal rejection and detachment. Permanent blindness. | ||